middle.news
How Artrya’s $0.6M U.S. Contract Signals a Commercial Breakthrough
8:58am on Monday 28th of July, 2025 AEST
•
Healthcare
Read Story
How Artrya’s $0.6M U.S. Contract Signals a Commercial Breakthrough
8:58am on Monday 28th of July, 2025 AEST
Key Points
U.S. commercial launch of Salix Coronary Anatomy platform completed
FDA submission filed for Salix Coronary Plaque module
Secured US$0.6 million five-year contract with Tanner Health
Leadership transition with Co-Founder John Konstantopoulos appointed CEO
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE